Biomolecular Engineering III: The design, engineering, and study of therapeutics and their disease targets | AIChE

Other Sites & Tools

Technical Groups

Biomolecular Engineering III: The design, engineering, and study of therapeutics and their disease targets

Chair(s)

Co-chair(s)

Bao, X., Purdue University
Deak, P., University of Chicago
Volpatti, L., University of Chicago

Biomolecular engineering approaches can be enabling technologies for the design and engineering of therapeutics as well as their disease targets. In this session, we highlight novel studies that describe both engineering of therapeutics as well as the study of important human disease targets. Presenters will further discuss vaccine antigen design, novel siRNA and gene therapy delivery methods, and anti-tumor immune modulation.

Presentations

8:00 AM
(306a) Unraveling the Energy Transition Network That Dictates Allosteric Activation of Proapoptotic High-Temperature Requirement Protease A2 for Therapeutic Intervention
8:18 AM
(306b) Mechanistic Insights into Differential Coreceptor Usage By HIV to Inform the Design of Novel Vaccine-Candidate Antigens
8:36 AM
(306c) Albumin-Binding Lipid-siRNA Conjugates Accumulate in Brain Endothelial Cells
8:54 AM
(306d) Adeno-Associated Virus-Based Gene Therapy to Treat Glioblastomas
9:12 AM
(27ab) Enzyme Function Prediction Using Contrastive Learning
9:30 AM
(306f) Programming Antitumor Immunity with Nanoscale Architecture
9:48 AM
(306g) Invited Talk: Systems Biology Approaches to Drug Discovery and Repurposing

Topics 

Biological Engineering

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

AIChE Pro Members $150.00
AIChE Emeritus Members $105.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00

More Conference Links